FindTrial
Sign In

A study to assess whether early laser treatment can improve the appearance of surgical scars after breast surgery

Early Fractional Laser Modulation Of Surgical Scars A Randomized Split-Scar, Three-Arm Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099298
Enrollment
45
Registered
2025-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L910- Hypertrophic scar

Interventions

Intervention1: Laser modulation (Co2 / Erbium glass) of surgical scars: Laser modulation (Co2 / Erbium glass) of surgical scars. Intervention2: Group A Erb:Glass (NAFL) Laser + Standard Care Grou

Sponsors

Department of Burns and Plastic Surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients undergoing the following surgeries - breast augmentation, double incision mastectomy, reduction mammoplasty and mastopexy 2) 3 weeks post-op or after suture removal 3) Willingness to adhere to follow-up

Exclusion criteria

Exclusion criteria: 1) Prior scar treatment (laser, PRP, intralesional steroid, microneedling) 2) Keloid/hypertrophic scar history 3) Uncontrolled diabetes or hypertension 4) Refusal of consent or inability to adhere to follow-up

Design outcomes

Primary

MeasureTime frame
To compare overall scar quality (Vancouver Scar Scale, VSS) at 6 months between the three groups (Erbium:Glass laser (NAFL) + standard care, CO2 laser (FAL) + standard care, Standard Care only (Silicone gel/ sheet)Timepoint: 3 weeks, 3 months and 6 months—

Secondary

MeasureTime frame
Changes in Scar Thickness and Echogenicity using High Frequency Ultrasound (HFUS) Patient satisfaction with scar quality (Likert scale) Incidence of adverse events (post-treatment hyperpigmentation [PTH], delayed healing, infection, pain)Timepoint: 3 weeks, 3 months and 6 months—

Countries

India

Contacts

Public ContactShivangi Saha

ALL INDIA INSTITUTE OF MEDICAL SCIENCES NEW DELHI

shivangisaha@gmail.com9968969174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026